Daten des Robert Koch-Instituts: 7-Tage-Inzidenz & Hospitalisierungen & GrippeWeb-Wochenbericht
Das aktuelle Corona-Krankheitsaufkommen in Deutschland beträgt schätzungsweise 188 Fälle pro 100.000 Einwohner, was bedeutet, dass ca. eine von 372 Personen derzeit akut infiziert ist (angenommen sind Ø 10 Tage Infektionsdauer). Das Robert-Koch-Institut (RKI) meldet eine auf meldepflichtigen PCR-Tests basierte Inzidenz von 1, wobei auf jede offiziell registrierte Infektion etwa 240 weitere unentdeckte Fälle entfallen. Informationen zur aktuellen Verteilung zirkulierender SARS-CoV-2-Varianten finden sich im RKI-Dashboard.
Die auf dem GrippeWeb-Wochenbericht basierte Inzidenz aller Atemwegserkrankungen beträgt 8.380 pro 100.000 Einwohner, was bedeutet, dass ca. eine von 12 Personen derzeit akut infiziert ist (angenommen sind Ø 7 Tage Infektionsdauer; Vergleich zu den Vorjahren). Stand: 10.03.2026
Der Risikorechner macht infektiöse Aerosol-Gefahren in Innenräumen sichtbar und unterstützt dabei, das tatsächliche Ansteckungsrisiko realistisch einzuschätzen.
Risiko berechnen
Rund um das Immunsystem gibt es viele Mythen und Missverständnisse. Dieser Text klärt einige häufige Fragen wissenschaftlich fundiert auf.
Weiterlesen
Depressive Symptoms in Patients With SARS-CoV-2 and Acute Coronary Syndrome 10.03.2026
Computational Study of Antibody Binding to SARS-CoV-2 Variants 10.03.2026
Serological profile of naïve patients affected by the first sars-cov-2 variant:A prospective study 10.03.2026
Modelling approaches for estimating vaccine effectiveness of consecutive SARS-CoV-2 variant sublineages in the absence of study-specific genetic sequencing data, VEBIS hospital network, Europe, 2023/24 10.03.2026
Retraction:Application of in-silico drug discovery techniques to discover a novel hit for target-specific inhibition of SARS-CoV-2 Mpro’s revealed allosteric binding with MAO-B receptor:A theoretical study to find a cure for post-covid neurological disorder 10.03.2026
Proteomic insights into troponin elevation following COVID-19 infection 10.03.2026
The Effect of SARS-CoV-2 on Bacterial Diversity and Abundance in Community Wastewater 10.03.2026
Non-clinical analysis of virus-like particles (VLP) containing SARS-CoV-2 vaccine antigens 10.03.2026
Erratum for Yuan et al., “Case-control and genomic epidemiology characterization of SARS-CoV-2 breakthrough infections during Delta-to-Omicron transition” 10.03.2026
Infection-acquired protection against SARS-CoV-2 infection and clinical severity by number of prior infections 10.03.2026
Ancestral Wuhan SARS-CoV-2 anti-spike CD4+ T cells predict protection from symptomatic omicron breakthrough infection 10.03.2026
Antiviral effect of cetylpyridinium chloride on SARS-CoV-2 in patients with COVID-19:An Observational Study 10.03.2026
Pneumonia due to respiratory syncytial virus does not cause long-lasting disorders in respiratory gas transport after clinical resolution in adults. Comparison vs. SARS-CoV-2 pneumonia. 09.03.2026
IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccination. 09.03.2026
Glycan-binding properties of SARS-CoV-2 spike proteins:interactions with aminoglycoside antibiotics. 09.03.2026
Amphotericin B promotes respiratory viral entry by enhancing late endosomal maturation and fusion via glucocerebrosidase-mediated ceramide remodeling. 09.03.2026
Infection-acquired protection against SARS-CoV-2 infection and clinical severity by number of prior infections. 09.03.2026
CoMBCR:Co-Learning Multi-Modalities of BCRs and Gene Expressions. 09.03.2026
Socioeconomic inequalities in the self-reported use of antibiotics in the European Union, 2009-2022:a repeated cross-sectional analysis. 09.03.2026
Serological profile of naïve patients affected by the first sars-cov-2 variant:A prospective study. 09.03.2026
Prevalence and associated factors of health facility delivery during COVID-19 in the Tamale Metropolis of Ghana:Analytical cross-sectional study. 09.03.2026
Influence of COVID-19 on postoperative prognosis and pain management. 09.03.2026
Modelling approaches for estimating vaccine effectiveness of consecutive SARS-CoV-2 variant sublineages in the absence of study-specific genetic sequencing data, VEBIS hospital network, Europe, 2023/24. 09.03.2026
Factors correlated with financial hardship among cancer patients during the COVID-19 pandemic. 09.03.2026
Retraction:Application of in-silico drug discovery techniques to discover a novel hit for target-specific inhibition of SARS-CoV-2 Mpro's revealed allosteric binding with MAO-B receptor:A theoretical study to find a cure for post-covid neurological disorder. 09.03.2026
Changing Prevalence of Immunocompromising Conditions in Patients Hospitalized with Severe Acute Respiratory Infection in Europe:Insights from the COVIDRIVE Study. 09.03.2026
Erratum for Yuan et al., "Case-control and genomic epidemiology characterization of SARS-CoV-2 breakthrough infections during Delta-to-Omicron transition". 09.03.2026
Glycan-binding properties of SARS-CoV-2 spike proteins:interactions with aminoglycoside antibiotics 09.03.2026
SARS-CoV-2 Spike Protein Sensing Using Photonic Crystal Fiber Technology 09.03.2026
Multi-Epitope DNA-Based Vaccine Targeting Nucleocapsid Protein of SARS-CoV-2:Immunoinformatic Design and In Vivo Validation 09.03.2026
Impact of omicron variant SARS-CoV-2 on tumor suppressor P53 gene expression and interferon-alpha downregulation during early infection 09.03.2026
Genomic Epidemiology of SARS-CoV-2 variants in unvaccinated children found to be similar to that of adults with COVID-19 vaccinations 09.03.2026
Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib:Integrating Literature Evidence and a Novel Observation 09.03.2026
Pneumonia due to respiratory syncytial virus does not cause long-lasting disorders in respiratory gas transport after clinical resolution in adults. Comparison <i>vs</i>. SARS-CoV-2 pneumonia 09.03.2026
Ugi multicomponent reactions of optically active aldehydes and chiral aminoindanols:diastereoselective synthesis of bisamides relevant to SARS-CoV-2 Mpro inhibitors 09.03.2026
Coordinated Immune Response Distinguishes Duration of SARS-CoV-2 Viral Particle Shedding in Humans 09.03.2026
Comparison of SARS-CoV-2 Variant Pathogenicity in a Long-COVID Syrian Hamster Model 09.03.2026
Etude de la prévalence de SARS COV-2 pendant la première vague de la pandémie à Kinshasa en 2020 09.03.2026
SARS−CoV−2 spike S1-mediated HIF−2α activation in retinal endothelial cells suggests a mechanism contributing to post−COVID endothelial dysfunction 09.03.2026
Assessment of biochemical and hematological profiles in outpatients with serological evidence of SARS-CoV-2 infection 09.03.2026
Emerging evidence from China indicates SARS- COV-2 may be associated with newly diagnosed Hashimoto’s thyroiditis:a clinical study of 54 patients with COVID-19 complicated by newly diagnosed disease 09.03.2026
The role of peripheral serotonin in SARS ‐ CoV ‐2 infectivity, COVID ‐19 treatment and long COVID 09.03.2026
SARS‐CoV‐2‐Induced Macrophage Polarization Reverses HIV‐1 Latency in J‐Lat Cells Through TNFα Signaling 09.03.2026
SARS‐CoV‐2 Main Protease Activates ERK1/2 Signaling to Facilitate MEG2–STAT3‐Mediated Suppression of ACE2 09.03.2026
Synthesis and biological evaluation of ibuprofen/o-vanillin Schiff base complexes with anti-inflammatory, anti-proliferative and anti-SARS-COV-19 activities 09.03.2026
Patterns of prescription stimulant initiation before and during the COVID-19 pandemic:a population-based time-series analysis. 08.03.2026
Incidencia y características clínicas de recién nacidos con sífilis congénita antes y durante la pandemia SARS-COV-2 en el Hospital General Materno Infantil San Pablo 08.03.2026
Inhibitory Effect of Curcuma xanthorrhiza Extract Against SARS‐CoV‐2 D614G Virus‐Like Particle (VLP):Implications for COVID‐19 Therapy Development 08.03.2026
Diagnostic Performance of Self‐Collected Respiratory Swabs for SARS‐CoV‐2 and Influenza Virus in Community‐Dwelling Older Adults 08.03.2026
Structural Basis of MERS‐CoV Receptor Interactions and Antibody Neutralisations 08.03.2026
Main Protease From SARS‐CoV‐2 Dysregulates Glucose Handling in the C2C12 Cell Line In Vitro:A Mechanistic Study 08.03.2026
Preserved T-Cell Immunity Despite Impaired Humoral Responses following SARS-CoV-2 Infection and Vaccination in Children with Profound B-cell Lymphopenia 08.03.2026
Longitudinal serological response to SARS-CoV-2 among rohingya refugees in cox’s bazar, Bangladesh:implications for pandemic preparedness in humanitarian settings 08.03.2026
Pediatric Admissions During the COVID ‐19 Pandemic in a Hospital With Low Prevalence of SARS ‐ CoV ‐2 08.03.2026
A Predictive Model for Rapid Assessment of Protective Efficacy Against Emerging SARS-CoV-2 Variants 08.03.2026
Length of SARS-CoV-2 shedding in HCT recipients:an Infectious Disease Working Party of EBMT study 08.03.2026
Repeated COVID-19 vaccine boosters elicit variant-specific memory B cells in humans. 06.03.2026
Inhibitory Effect of Curcuma xanthorrhiza Extract Against SARS-CoV-2 D614G Virus-Like Particle (VLP):Implications for COVID-19 Therapy Development. 04.03.2026
TMEM259/MEMBRALIN is a non-canonical ER-phagy receptor that associates with MAN1B1 and VCP to eliminate viral glycoproteins. 03.03.2026
Will animal reservoirs give us the next SARS-CoV-2 variant? 03.03.2026
Spike destabilization attenuates Mink Cluster 5 SARS-CoV-2. 03.03.2026
Viruses (Including SARS-CoV-2), Nematodes and Their Spread 02.03.2026
Armored RNA technology as a clinical diagnostics tool for future pandemic preparedness. 28.02.2026
Welding fumes and SARS-CoV-2:a dangerous combination. 25.02.2026
Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer-Results of the PD-RAD Study. 24.02.2026
Impact of Smoking on Household SARS-CoV-2 Transmission. 22.02.2026
Aerosolization effects on coronavirus infectivity. 20.02.2026
The effect of the COVID-19 pandemic on TNM status among head and neck cancer patients in Hungary. 20.02.2026
Tele-neurology in Latin America:digital solutions for a treatment gap. 20.02.2026
Epidemiological characteristics and risk factors for severity of product-related injuries in children during COVID-19:a non-pharmaceutical intervention study. 20.02.2026
Impact of in vitro diagnostic tests in health, society and economy in Portugal. 20.02.2026
mRNA-based SARS-CoV-2 vaccines:intracellular processing and aggregation of the encoded spike protein as a mechanistic contributor to cardiac cellular stress. 20.02.2026
The effect of unemployment on suicidal ideation among men:evidence from Australia during the COVID-19 pandemic. 19.02.2026
Influence of SARS-CoV-2 reinfection on bone health in the population over 55 years old in Beijing, China:a cross-sectional study. 19.02.2026
Historical texts as a potential resource for plant-based antiviral agents against SARS-CoV-2:the example of the Receptarium of Burkhard III von Hallwyl from 16th-century Switzerland. 19.02.2026
Screening of wild roe deer populations in Sweden 2016-2022 for SARS-CoV-2. 19.02.2026
Successful Treatment of Multiple Myeloma Complicated With SARS-CoV-2 Infection:A Case Report. 18.02.2026
Impact of SARS-CoV-2 on Dental Practice:A Comprehensive Narrative Review 18.02.2026
Lymphopenia in Bacterial Sepsis and SARS-CoV-2 Infection. 15.02.2026
Challenges and Prospects in the Development of a Universal SARS-CoV-2 Vaccine. 13.02.2026
Changes in youth public psychiatric service utilization during the COVID-19 pandemic in Italy:an observational study. 09.02.2026
Host Glycan-Lectin Interplay in SARS-CoV-2 Infection. 06.02.2026
SARS-CoV-2 Infection and Vaccination, Immune Dysregulation, and Cancer 03.02.2026
Impact of Smoking on Household SARS-CoV-2 Transmission 01.02.2026
Therapeutic Approaches to Treat SARS-CoV-2. 01.02.2026
Lymphopenia in Bacterial Sepsis and SARS-CoV-2 Infection 01.02.2026
Genetic and Structural Analyses of Coronaviruses:Insights into SARS-CoV-2 and Beyond 01.02.2026
SARS-CoV-2 Chronic Intervillositis:Variations of Maternal Antiviral Response. 01.02.2026
A Systematic Review of Methodological Approaches to SARS-CoV-2 Wastewater Surveillance 01.02.2026
SARS-CoV-2 vaccination and myositis in Norway and Sweden. 01.02.2026
Tracing SARS-CoV-2 Evolution in Algeria:Insights from 2020 to 2023 01.02.2026
Molecular Characterization of Persistent SARS-CoV-2 Infections in Immunocompromised Patients 30.01.2026
Influenza-Infected Pigs Are Not Susceptible to SARS-CoV-2 Infection 26.01.2026
Influenza-Infected Pigs Are Not Susceptible to SARS-CoV-2 Infection. 26.01.2026
Structural mimics of SARS-CoV-2. 22.01.2026
CACHE Challenge #3:Targeting the Nsp3 Macrodomain of SARS-CoV-2. 21.01.2026
A feasibility study using the ETL CoronaCheck® device to identify incident cases of SARS-CoV-2:FIND SARS-CoV-2. 20.01.2026
Energy Measures as Biomarkers of SARS-CoV-2 Variants and Receptors. 16.01.2026
[Experiences from SARS-CoV-2 pandemic at UKSH Lübeck]. 13.01.2026
Host Responses to SARS-CoV-2 with an Emphasis on Cytokines. 09.01.2026
Quellen: PubMed, Europe PMC & CrossRef
Nur noch ein Piks nötig: Kombi-Impfung gegen Covid und Grippe kommt - CHIP 10.03.2026
Bekannt durch Covid-Impfstoff: Biontech-Gründungspaar verlässt das Unternehmen - swp.de 10.03.2026
Endlich Klarheit? Neue Hinweise zum Ursprung von Covid-19 - TAG24 10.03.2026
Nordkorea und China reaktivieren Zugverbindung nach Unterbrechung wegen Covid-19 - Spiegel 10.03.2026
Selbsthilfegruppe Post Vac und Long Covid in Biblis-Nordheim - Mannheimer Morgen 09.03.2026
Zwei harte Grippewinter, während Covid im Hintergrund blieb – Was steckt dahinter? - Frankfurter Rundschau 09.03.2026
Teilerfolg für Klage gegen Astrazeneca nach COVID-19-Impfung - Biermann Medizin 09.03.2026
Long Covid: Der Marburger Professor Bernhard Schieffer (UKGM) über die Folgen von Corona - Oberhessische Presse 09.03.2026
BAG legt Verträge zur Beschaffung von Covid-Impfstoffen offen - SRF 09.03.2026
Nach Gerichtsurteil - Bund soll Covid-Impfstoffverträge offenlegen - Plattform J 09.03.2026
Teilerfolg für Klage gegen Impfstoffhersteller AstraZeneca - tagesschau.de 09.03.2026
Oberlandesgericht Koblenz muss Klage gegen Astrazeneca zu Hörsturz nach Coronaimpfung neu verhandeln - Spiegel 09.03.2026
Beschädigte Mitochondrien werden nicht entsorgt - Deutsche Apotheker Zeitung, DAZ 09.03.2026
Die Zero-Covid-Ideologen suchen sich neue Spielfelder | Cicero Online - Cicero Online 07.03.2026
Long-Covid-Kolumne: Das zieht sich aber bei dir - Apotheken Umschau 03.03.2026
Long COVID und Post‐COVID - Landeshauptstadt Stuttgart 26.02.2026
Was eine gute Reha beim Post-COVID-Syndrom ausmacht - Ärzte Zeitung 23.02.2026
Neue Corona-Varianten: Wie hat sich das SARS-Cov-2-Virus verändert? - MDR.DE 30.12.2025
Long Covid bei Kindern: Wie läuft die Versorgung in Hamburg? - NDR.de 16.12.2025
Long COVID, ME/CFS & Post-Vac: Betroffene stärken – Wissen teilen - Portal Niedersachsen 12.11.2025
Quelle: Google News
Pluslife ist ein Molekulartest (PoC-NAT) für zuhause: besser als Antigen-Schnelltests bei niedriger Viruslast – und mit Analyzer-Webapp von »virus.sucks« werden Ergebnisse nachvollziehbar.
Safe Air Docs hilft dabei, Arztpraxen mit hohen Infektionsschutzstandards zu finden. So wird der Arztbesuch sicherer – besonders für Menschen mit erhöhtem Gesundheitsrisiko.
Am 15. und 16. Mai 2024 fand die virtuelle Konferenz #UniteToFight2024 statt und zog über 10.000 Teilnehmer an, die sich über die neuesten Entwicklungen zu Long Covid und ME/CFS informierten. Führende Experten wie Dr. David Putrino und Prof. Akiko Iwasaki präsentierten aktuelle Forschungsergebnisse.
Die Übertragung durch Aerosole ist einer der am schwierigsten zu vermeidenden Infektionswege, kann aber durch FFP2- und FFP3-Masken effektiv blockiert werden.
2023: Golda Schlaff und 15 weitere prominente Ärzt:innen fordern mehr Respekt vor den Patient:innen, die Wiedereinführung von FFP2-Masken bei steigenden Inzidenzen sowie den flächendeckenden Einsatz von HEPA-Filtern in medizinischen Einrichtungen.